Coarse Ventricular Fibrillation

Pre-clinical study (experimental & clinical testing)

Type: Pre-clinical study, Clinical control. With a standardized time interval between the end of one day's pre-treatment and the start of the second day’s post-treatment. As the duration of this process is too short to give accurate results, we only use an interim baseline value on which to base our proposed intervention time intervals. In this way, our intervention is tested within a 'flat' or linear range. These interventions are not aimed at increasing symptom scores. We feel that these approaches can be used effectively in small patient populations where patients are measured with conventional chest X-ray images. The visual clinical displays provided using this type of imaging are more visible than chest radiograph-based score analysis and may also assist clinicians to assess patients if necessary. Two different types of intervention studies are mentioned below for performing such visual clinical presentations. We wish to expand this space over time by producing multiple resources on assessing tachyarrhythmias using vision. A possible timeline is illustrated below depicting how the other studies have progressed.

Visual Clinical Presentation Application in Clinics

These are simple observations from clinicians that we have collected based on their experience in daily clinic practice alongside continuous observation from an Australian clinician who has studied visual clinical presentation features in other countries like Italy & USA. There is also practical application when designing measures: ‘do-be-color’, ‘imaging vs. dynamic clinical presentation’ with best practice scoring guidelines listed on this page. We hope you will find it useful. Check out the first two videos and try ‘doing do-be-color’ yourself. It is quick and easy – just click once! We now anticipate being able to release the resources including methodology tools as soon as September 2018. We also plan to create a signposting resource explaining the rationale behind looking for early auditory signs rather than always solely seeking imaging/resonance clues alone. We believe that ultimately this project will help aid clinicians looking for subtle subtle signs throughout their population whilst integrating visual presentations into routine clinical examination.

As well as helping address existing gaps in global understanding of TAVR evaluation during management following TVCF, visual clinical presentation measurements will allow us to determine how much diagnostic variability exists amongst treatment modalities.